Icosabutate not checked

NorthSea Therapeutics B.V. · NST-4016

FollowEvery change as it happens, and a Monday email
Stage
No active trials
 
Next date
None yet
 
Trials
0 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Non Alcoholic Steatohepatitis (NASH)
Main trialPhase 2
“A Phase 2b study to evaluate the efficacy of different doses of NST-4016 on the resolution of NASH without worsening of fibrosis”In the company’s words, NCT04052516 on ClinicalTrials.gov
Other names
NST-4016

Other drugs for Non Alcoholic Steatohepatitis (NASH)

All 30 drugs for Non Alcoholic Steatohepatitis (NASH)

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Completed 20 Feb 2022 A Phase 2b Study of Icosabutate in Fatty Liver Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Icosabutate

Following is part of Solo: you see every change to Icosabutate the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in